Man, cancer and immunity /

Man, cancer and immunity /

42

Bibliographic Details
Main Author:	189669 Cochran, Alistair J.
Format:
Published:	London : Academic, 1978
Subjects:	Cancer Tumor antigens Immunotherapy

Similar Items

Identification of TTLL8, POTEE, and PKMYT1 as immunogenic cancer-associated antigens and potential immunotherapy targets in ovarian cancer
by: Esen Yonca Bassoy, et al.
Published: (2025-12-01)

Challenges and New Directions in Therapeutic Cancer Vaccine Development
by: Danjie Pan, et al.
Published: (2024-11-01)

Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
by: Violeta Delgado-Almenta, et al.
Published: (2025-02-01)

Efficient Predictor for Immunotherapy Efficacy: Detecting Pan‐Clones Effector Tumor Antigen‐Specific T Cells in Blood by Nanoparticles Loading Whole Tumor Antigens
by: Weibiao Zeng, et al.
Published: (2025-01-01)

EFFECT OF ANTIGEN-PRIMED DENDRITIC CELL-BASED IMMUNOTHERAPY ON ANTITUMOR CELLULAR IMMUNE RESPONSE IN PATIENTS WITH COLORECTAL CANCER
by: V. V. Kurilin, et al.
Published: (2021-10-01)

Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response
by: Weisen Ning, et al.
Published: (2025-01-01)

CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01)

Novel mRNA adjuvant ImmunER enhances prostate cancer tumor-associated antigen mRNA therapy via augmenting T cell activity
by: Zhen Xu, et al.
Published: (2024-12-01)

EFFICIENCY OF THE FORMATION OF ANTITUMOR IMMUNE RESPONSES IN THE SYSTEM OF PREVENTIVE VACCINATION OF MICE WITH TESTICULAR ANTIGENS
by: A. B. Dorzhieva, et al.
Published: (2021-10-01)

mRNA vaccines in the context of cancer treatment: from concept to application
by: Qiang Fu, et al.
Published: (2025-01-01)

Clinical significance of the tumor microenvironment on immune tolerance in gastric cancer
by: Xiangyang He, et al.
Published: (2025-02-01)

Mutation of lysine-specific demethylase 5 is associated with enhanced tumor immunity and favorable outcomes in pan-cancer immune checkpoint blockade
by: Xiaofeng Li, et al.
Published: (2024-12-01)

Association between human leukocyte antigen E expression and outcomes in solid tumors: a systematic review and meta-analysis
by: Javier David Benitez Fuentes, et al.
Published: (2025-02-01)

LADS: a powerful vaccine platform for cancer immunotherapy and prevention
by: Jing Sun, et al.
Published: (2024-12-01)

Current advances on the role of ferroptosis in tumor immune evasion
by: Changlin Gao, et al.
Published: (2024-12-01)

Pre-injection of exosomes can significantly suppress ovarian cancer growth by activating the immune system in mice
by: Yuanyuan Wang, et al.
Published: (2025-02-01)

Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening
by: Siyu Zhang, et al.
Published: (2024-10-01)

Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery
by: Ibeanu GC, et al.
Published: (2024-12-01)

Corrigendum: Anti-cancer immune effect of human colorectal cancer neoantigen peptide based on MHC class I molecular affinity screening
by: Siyu Zhang, et al.
Published: (2024-12-01)

Salmonella immunotherapy engineered with highly efficient tumor antigen coating establishes antigen-specific CD8+ T cell immunity and increases in antitumor efficacy with type I interferon combination therapy
by: Suyang Wang, et al.
Published: (2024-12-01)

Tumor-stroma proportion is associated with increased M2 macrophage abundance and predicts the resistance to immune checkpoint blockade in breast cancer
by: Yincheng Liu, et al.
Published: (2025-04-01)

Immune regulatory genes impact the hot/cold tumor microenvironment, affecting cancer treatment and patient outcomes
by: Mengmeng Sang, et al.
Published: (2025-01-01)

FEATURES OF LOCAL IMMUNITY IN PATIENTS WITH OROPHARYNGEAL CANCER
by: O. I. Keith, et al.
Published: (2017-11-01)

Tandem CAR-T cell therapy: recent advances and current challenges
by: Sara Gómez-Melero, et al.
Published: (2025-02-01)

Transcriptome analysis of ovarian cancer uncovers association between tumor-related inflammation/immunity and patient outcome
by: Jingfang Wang, et al.
Published: (2025-02-01)

Deciphering the mechanisms of cross-presentation for exogenous ROPs through their interaction with cathepsin S
by: Stephens, AJ
Published: (2023)

Advances in the role of tumor-associated neutrophils in the development of breast cancer
by: XU Rui, WANG Zehao, WU Jiong
Published: (2024-09-01)

The interplay between persistent pathogen infections with tumor microenvironment and immunotherapy in cancer
by: Si Chen, et al.
Published: (2024-09-01)

Tumor secretome shapes the immune landscape during cancer progression
by: Jianqiang Yang, et al.
Published: (2025-02-01)

Cancer vaccines: platforms and current progress
by: Wanting Lei, et al.
Published: (2025-01-01)

TRANSCRIPTIONAL PROFILE OF CANCER-TESTICULAR ANTIGENS IN PATIENTS WITH BREAST CANCER
by: D. I. Vodolazhskiy, et al.
Published: (2018-06-01)

Enhancing T cell anti-tumor efficacy with a PD1-TIGIT chimeric immune-checkpoint switch receptor
by: Jingjing Zhao, et al.
Published: (2023-12-01)

Cancer vaccines: current status and future directions
by: Yingqiong Zhou, et al.
Published: (2025-02-01)

Therapeutic effect of local hyperthermia treatment combined with anti-CD200 immunotherapy in EMT6 breast cancer
by: Wan Mohd Zawawi, Wan Fatin Amira
Published: (2023)

Integrative pan-cancer analysis and experiment validation identified GLS as a biomarker in tumor progression, prognosis, immune microenvironment, and immunotherapy
by: Dongming Li, et al.
Published: (2025-01-01)

Prognostic Significance and Immune Landscape of a Cuproptosis-Related LncRNA Signature in Ovarian Cancer
by: Min Zhou, et al.
Published: (2024-11-01)

Editorial: Deciphering the regulatory role of transcription factors in cancer immune infiltration
by: Qian Yang, et al.
Published: (2025-02-01)

A self-activated and protective module enhances the preclinical performance of allogeneic anti-CD70 CAR-T cells
by: Zhao Zhang, et al.
Published: (2025-01-01)

Prospects for Treatment of Lung Cancer Using Activated Lymphocytes Combined with Other Anti-Cancer Modalities
by: Anastasia Ganina, et al.
Published: (2024-12-01)

Integrated Profiling Delineated KIF18A as a Significant Biomarker Associated with Both Prognostic Outcomes and Immune Response in Pancreatic Cancer
by: Nan K, et al.
Published: (2025-02-01)